ALX Oncology Holdings Inc. (ALXO) Covered Calls

You can sell covered calls on ALX Oncology Holdings Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ALXO (prices last updated Fri 4:16 PM ET):

ALX Oncology Holdings Inc. (ALXO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
16.86 -0.01 13.75 17.50 461K - 0.8
Covered Calls For ALX Oncology Holdings Inc. (ALXO)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 17.5 0.30 17.20 1.7% 28.2%
Jun 21 17 2.00 15.50 9.7% 62.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic used for the treatment of myelodysplastic syndromes and acute myeloid leukemia, as well as a range of solid tumor indications, including head and neck squamous cell and human epidermal growth factor receptor 2 positive gastric/gastroesophageal junction carcinoma. The company was founded in 2015 and is based in Burlingame, California.